Article
Cellular Genome-scale Metabolic Modeling Identifies New Potential Drug Targets Against Hepatocellular Carcinoma
2021-12-06
Abstract excerpt
Hepatocellular carcinoma is the third leading cause of cancer related mortality worldwide. Often this hepatic cancer is associated with fatty liver disease and insulin resistance with genetic predisposition are its major driver. Genome-scale metabolic modeling (GEM) is a promising approach to understand cancer metabolism and to identify new drug targets. Here, we used TRFBA-CORE, an algorithm generating a model us...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- cc6dc1fc-6428-52f1-9b1d-3f55ccf6d469
- DOI
- 10.21203/rs.3.rs-1120182/v1
